adenoviral methioninase gene therapy/selenomethionine GDEPT (AntiCancer)

N/A

Report date: 2025/03/14 16:36:36

Base Information

Drug Nameadenoviral methioninase gene therapy/selenomethionine GDEPT (AntiCancer)
Drug Alias NameAd-MET/SeMET GDEPT (AntiCancer)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnticancer Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnticancer Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A